1. Home
  2. ATS vs AVDL Comparison

ATS vs AVDL Comparison

Compare ATS & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$29.33

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.56

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
AVDL
Founded
1978
2015
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
ATS
AVDL
Price
$29.33
$21.56
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$35.00
$19.14
AVG Volume (30 Days)
115.9K
1.5M
Earning Date
02-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,930,283,080.00
$248,517,000.00
Revenue This Year
$16.92
$65.47
Revenue Next Year
$5.13
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.88
52 Week Low
$20.90
$6.38
52 Week High
$32.73
$23.57

Technical Indicators

Market Signals
Indicator
ATS
AVDL
Relative Strength Index (RSI) 53.15 60.82
Support Level $28.96 $21.51
Resistance Level $29.92 $21.65
Average True Range (ATR) 0.93 0.07
MACD -0.09 -0.02
Stochastic Oscillator 55.86 66.67

Price Performance

Historical Comparison
ATS
AVDL

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: